Investing.com — Dr Martens (LON:DOCS) reaffirmed its fiscal 2027 outlook on Wednesday, pointing to encouraging wholesale demand in the United States, its largest market.

The British bootmaker said trading has been in line with expectations since its financial year began in April.

The company reported that Japan and South Korea were performing well. European markets also met expectations despite a challenging consumer backdrop.

In May, Dr Martens reported a revenue decline from the Europe, Middle East and Africa region as the economic fallout from the Iran war weighed on consumer spending.

The company is expected to report adjusted pretax profit of £68 million ($91.21 million) for fiscal 2027, according to a company-compiled consensus.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.